[
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04184882",
        "briefTitle": "A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2021-02-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-12-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Astellas Pharma Inc"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03179631",
        "briefTitle": "Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-06-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophies",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Musculoskeletal Disease",
          "Neuromuscular Diseases",
          "Nervous System Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02018731",
        "briefTitle": "L-citrulline and Metformin in Becker's Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-12-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-05-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Basel, Switzerland"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker's Muscular Dystrophy (BMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  }
]